Has Michael Hossack, MD received payments from drug or device companies?

Yes. Drug and device makers reported $39,729 in general payments to Michael Hossack, MD across 200 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Hossack, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Hossack, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Hossack, MD

Sports Medicine · Bronx, NYNPI 1902947450

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,000 of the $39,729 with a category attached, or 73.0%. Zimmer Biomet accounts for 92.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $26,581 and has fallen 97.5% since, to $661 in 2025.

$39,729in general payments, 2019–2025

Across 200 payments — averaging $198.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$37K
Smith+Nephew$2K
Embody, Inc.$145
Amgen$139
Johnson & Johnson$49
AstraZeneca$36
plus $24 from 1 others

What the payments were for

Consulting fees$29,00073%
Travel & lodging$6,64517%
Food & beverage$4,08410%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	70	$36,920
Smith+Nephew	116	$2,416
Embody, Inc.	1	$145
Amgen	8	$139
Johnson & Johnson	2	$49
AstraZeneca	2	$36
Gotham Surgical Solutions & Devices, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,729 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York →

Medicare billing

Part B allowed, 2024

$14,101

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Bronx

Steven LeeNyc$3.3M
James PaciWoodbury$2.1M
Gregory DifeliceNew York$1.8M
Ilya VoloshinRochester$786K
Theodore BlaineNew York$765K
Robert MeislinNew York$720K
Danyal NawabiNew York$592K
Stephen NicholasNyc$586K
Riley WilliamsNew York$512K
Bryan KellyNew York$409K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →